Author

M-L Dahl

Observed names: M L Dahl, ML Dahl, M‐L. Dahl

Institutions: Karolinska University Hospital, Karolinska Institutet

Observed institutions: Uppsala University, Karolinska University Hospital, Uppsala University Hospital, Karolinska Institutet, University of Tartu

OpenAlex ID: A5111598172

Clozapine disposition covaries with CYP1A2 activity determined by a caffeine test.

1994 · L Bertilsson, JA Carrillo, et al. · British Journal of Clinical Pharmacology · 306

Molecular basis for rational megaprescribing in ultrarapid hydroxylators of debrisoquine

1993 · L Bertilsson, M-L Dahl, et al. · The Lancet · 222

Interphenotype differences in disposition and effect on gastrin levels of omeprazole—suitability of omeprazole as a probe for CYP2C19.

1995 · M Chang, G Tybring, et al. · British Journal of Clinical Pharmacology · 183

A PK–PD Model for Predicting the Impact of Age, CYP2C9, and VKORC1 Genotype on Individualization of Warfarin Therapy

2007 · A-K Hamberg, M-L Dahl, et al. · Clinical Pharmacology & Therapeutics · 144

Pharmacodynamics of Carbamazepine-mediated Induction of CYP3A4, CYP1A2, and Pgp as Assessed by Probe Substrates Midazolam, Caffeine, and Digoxin

2007 · MO Magnusson, M-L Dahl, et al. · Clinical Pharmacology & Therapeutics · 90

Patterns of drug treatment of schizophrenic patients in Estonia, Spain and Sweden.

1995 · RA Kiivet, A. Llerena, et al. · British Journal of Clinical Pharmacology · 57

Intra-individual variation and sex differences in gene expression of cytochromes P450 in circulating leukocytes

2002 · N Finnström, B Ask, et al. · The Pharmacogenomics Journal · 46

Influence of FMO1 and 3 polymorphisms on serum olanzapine and its N-oxide metabolite in psychiatric patients

2012 · M M Söderberg, T Haslemo, et al. · The Pharmacogenomics Journal · 30

Therapeutic monitoring of antiepileptic drugs for epilepsy

2006 · T Tomson, ML Dahl, et al. · Cochrane Database of Systematic Reviews · 19

Disposition of debrisoquine and nortriptyline in Korean subjects in relation to CYP2D6 genotypes, and comparison with Caucasians

2003 · P. Dalén, M‐L. Dahl, et al. · British Journal of Clinical Pharmacology · 15

[Genotyping for drug metabolism capacity can give valuable clinical information].

1992 · M Ingelman-Sundberg, I Johansson, et al. · PubMed · 2

Abstract PD10-09: CYP2D6 and adjuvant tamoxifen: Impact on outcome in pre- but not postmenopausal breast cancer patients

2012 · S Margolin, J Lindh, et al. · Cancer Research · 1

U-60,257 has no effect on the metabolism of arachidonic acid in nonstimulated human polymorphonuclear leukocytes.

1984 · M L Dahl, T Puustinen, et al. · PubMed · 1

TDM of psychoactive drugs in Sweden

2016 · ML Dahl · Pharmacopsychiatry

[Knowledge about metabolic capacity is important in drug therapy].

1992 · G Alván, M L Dahl · PubMed

[Abuse potential of benzodiazepines. Sensible use means continuous follow-up].

1990 · U Bergman, M L Dahl, et al. · PubMed

Works count: 16

Citation count: 1,116

H-index: 10

I10-index: 10